Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Stats
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Linda Hogarth
Newcastle Authors
Title
Year
Full text
Dr Nicola Wyatt
Dr Linda Hogarth
Dianne Turner
Dr Miranda Patterson
Dr David Jamieson
et al.
Circulating Biomarkers of Frailty Are Associated with a Poor Prognosis in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
2016
Dr Alastair Greystoke
Dr Linda Hogarth
Dr Miranda Morton
Liam Bolt
Dianne Turner
et al.
The introduction of the Cancer Research UK Stratified Medicine Programme 2 (CRUK SMP2) in North East England; lessons learned and experience gained
2016
Dr Linda Hogarth
Emeritus Professor Andy Hall
p21
WAF1
modulates drug-induced apoptosis and cell cycle arrest in B-cell precursor acute lymphoblastic leukemia
2015
Dr Nicola Cresti
Dr Linda Hogarth
Phase I expansion of S-222611, a reversible inhibitor of EGFR and HER2, in advanced solid tumors, including patients with brain metastases.
2015
Dr Sally Coulthard
Dr Chris Redfern
Svante Vikingsson
Dr Malin Lindqvist Appell
Emeritus Professor Andy Hall
et al.
Increased Sensitivity to Thiopurines in Methylthioadenosine Phosphorylase-Deleted Cancers
2011
Dr Linda Hogarth
Emeritus Professor Andy Hall
p53-independent Epigenetic Repression of the p21
WAF1
Gene in T-cell Acute Lymphoblastic Leukemia
2011
Dr Sally Coulthard
Dr Chris Redfern
Dr Linda Hogarth
Increased sensitivity to thiopurines in methylthioadenosine phosphorylase-deleted cancers [abstract]
2010
Dr Linda Hogarth
Dr Chris Redfern
Emeritus Professor Andy Hall
Dr Holly Anderson
Marian Case
et al.
The effect of thiopurine drugs on DNA methylation in relation to TPMT expression
2008
Elizabeth Matheson
Dr Linda Hogarth
Marian Case
Professor Julie Irving
Emeritus Professor Andy Hall
et al.
DHFR and MSH3 co-amplification in childhood acute lymphoblastic leukaemia,
in vitro
and
in vivo
2007
Marian Case
Emeritus Professor Andy Hall
Dr Linda Hogarth
Amanda Jones
Design, synthesis and initial in vitro evaluation of novel prodrugs for the treatment of cystinosis
2006
1
2
3
4